drugset / Trial / NCT01550484

A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders

NCT01550484

Phase 2/3 Completed 170 enrolled Avid Radiopharmaceuticals
NaSingle-groupSingle-blindDiagnostic

Summary

The purpose of this study is to determine whether 18F-AV-133 PET scans can be used to differentiate subjects with Parkinson's Disease from other movement disorders.

Timeline

Start
2012-04
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DTBZ Diagnostic / imaging agent 222 mbq